Astellas Pharma (ALPMY) Short Interest Ratio & Short Volume $9.85 +0.13 (+1.34%) As of 03:58 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest Astellas Pharma Short Interest DataAstellas Pharma (ALPMY) has a short interest of 57,000 shares, representing 0.00% of the float (the number of shares available for trading by the public). This marks a 20.76% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 220,421 shares to cover all short positions.Current Short Interest57,000 sharesPrevious Short Interest47,200 sharesChange Vs. Previous Month+20.76%Dollar Volume Sold Short$553,470.00Short Interest Ratio0.3 Days to CoverLast Record DateFebruary 28, 2025Outstanding Shares1,809,663,000 sharesShort Percent of Float0.00%Today's Trading Volume170,370 sharesAverage Trading Volume220,421 sharesToday's Volume Vs. Average77% Short Selling Astellas Pharma? Sign up to receive the latest short interest report for Astellas Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartALPMY Short Interest Over TimeALPMY Days to Cover Over TimeALPMY Percentage of Float Shorted Over Time Remove Ads Astellas Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/28/202557,000 shares $553,470.00 +20.8%0.0%0.3 $9.71 2/15/202547,200 shares $461,144.00 -49.0%0.0%0.1 $9.77 1/31/202592,500 shares $895,400.00 +132.4%N/A0.2 $9.68 1/15/202539,800 shares $385,861.00 +26.4%N/A0.1 $9.70 12/31/202431,500 shares $304,290.00 -58.7%N/A0 $9.66 12/15/202476,200 shares $768,096.00 +150.7%N/A0.1 $10.08 11/30/202430,400 shares $315,552.00 -69.8%N/A0.1 $10.38 11/15/2024100,500 shares $1.08 million +1,004.4%N/A0.3 $10.70 10/31/20249,100 shares $106,288.00 -79.8%N/A0.1 $11.68 10/15/202445,100 shares $517,297.00 +16.2%N/A0.2 $11.47 Get the Latest News and Ratings for ALPMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Astellas Pharma and its competitors with MarketBeat's FREE daily newsletter. 9/30/202438,800 shares $444,260.00 +269.5%N/A0.3 $11.45 9/15/202410,500 shares $126,105.00 -75.4%N/A0.1 $12.01 8/31/202442,600 shares $528,666.00 +38.8%N/A0.3 $12.41 8/15/202430,700 shares $351,208.00 -89.7%N/A0.1 $11.44 7/31/2024298,700 shares $3.47 million -11.9%N/A0.6 $11.61 7/15/2024338,900 shares $3.53 million +48.8%N/A1 $10.42 6/30/2024227,800 shares $2.25 million -10.5%N/A0.4 $9.86 6/15/2024254,500 shares $2.42 million +83.5%N/A0.3 $9.51 5/31/2024138,700 shares $1.36 million +87.2%N/A0.2 $9.81 5/15/202474,100 shares $726,180.00 -11.7%N/A0.1 $9.80 4/30/202483,900 shares $801,245.00 +20.2%N/A0.1 $9.55 4/15/202469,800 shares $647,150.70 -59.4%N/A0.1 $9.27 3/31/2024171,800 shares $1.85 million +53.1%N/A0.3 $10.75 3/15/2024112,200 shares $1.21 million +51.6%N/A0.2 $10.83 2/29/202474,000 shares $808,820.00 +9.1%N/A0.2 $10.93 2/15/202467,800 shares $749,190.00 -19.7%N/A0.1 $11.05 1/15/202468,200 shares $823,856.00 -57.1%N/A0.2 $12.08 12/31/2023159,100 shares $1.89 million +305.9%N/A0.3 $11.90 12/15/202339,200 shares $445,312.00 -14.6%N/A0 $11.36 11/30/202345,900 shares $558,144.00 -7.8%N/A0.1 $12.16 11/15/202349,800 shares $579,921.00 +3.8%N/A0.1 $11.65 10/31/202348,000 shares $609,120.00 +1,197.3%N/A0.1 $12.69 10/15/20233,700 shares $48,248.00 -27.5%N/A0 $13.04 9/30/20235,100 shares $70,635.00 -54.1%N/A0 $13.85 9/15/202311,100 shares $165,501.00 -74.7%N/A0 $14.91 8/31/202343,900 shares $664,646.00 -43.9%N/A0.2 $15.14 8/15/202378,200 shares $1.18 million -38.0%N/A0.3 $15.13 7/31/2023126,200 shares $1.85 million +94.8%N/A0.3 $14.63 7/15/202364,800 shares $933,120.00 +9,157.1%N/A0.2 $14.40 6/30/2023700 shares $10,409.00 -98.3%N/A0 $14.87Silent Raid on IRAs and 401(k)s Begins—Are You Next? (Ad)Look around—everything feels oddly steady. Gas prices aren't skyrocketing. Banks aren't collapsing. The markets? They're holding up—for now. But if history has taught us anything, it's this: when things feel too quiet, chaos is right around the corner.Avoid this chaos, click here to get your free guide. 6/15/202340,900 shares $659,308.00 -32.2%N/A0.5 $16.12 5/31/202360,300 shares $950,931.00 +61.2%N/A0.3 $15.77 5/15/202337,400 shares $599,522.00 +77.3%N/A0.4 $16.03 4/30/202321,100 shares $316,922.00 +64.8%N/A0.3 $15.02 4/15/202312,800 shares $189,568.00 -60.7%N/A0.1 $14.81 3/31/202332,600 shares $462,757.00 -26.4%N/A0.2 $14.20 3/15/202344,300 shares $610,011.00 -15.8%N/A0.2 $13.77 2/28/202352,600 shares $736,400.00 +310.9%N/A0.2 $14.00 2/15/202312,800 shares $183,936.00 +75.3%N/A0.1 $14.37 1/31/20237,300 shares $107,164.00 -73.7%N/A0 $14.68 1/15/202327,700 shares $404,974.00 -43.7%N/A0.2 $14.62 12/30/202249,200 shares $745,872.00 +278.5%N/A0.5 $15.16 12/15/202213,000 shares $202,410.00 -75.8%N/A0.2 $15.57 11/30/202253,600 shares $828,656.00 -48.9%N/A0.5 $15.46 11/15/2022104,900 shares $1.58 million +88.3%N/A0.4 $15.07 10/31/202255,700 shares $772,002.00 -50.2%N/A0.2 $13.86 10/15/2022111,900 shares $1.49 million +5.3%N/A0.3 $13.33 9/30/2022106,300 shares $1.42 million +544.2%N/A0.2 $13.33 9/15/202216,500 shares $227,205.00 No ChangeN/A0 $13.77 8/15/20222,000 shares $30,600.00 -95.6%N/A0 $15.30 7/31/202245,100 shares $702,207.00 -32.5%N/A0.2 $15.57 7/15/202266,800 shares $1.06 million -63.5%N/A0.5 $15.82 6/30/2022183,100 shares $2.85 million +367.1%N/A0.8 $15.56 6/15/202239,200 shares $587,216.00 +1,087.9%N/A0.2 $14.98 5/31/20223,300 shares $52,503.00 -85.3%N/A0 $15.91 5/15/202222,400 shares $339,360.00 -62.5%N/A0.1 $15.15 4/30/202259,700 shares $905,649.00 +69.1%N/A0.3 $15.17 4/15/202235,300 shares $580,685.00 +451.6%N/A0.2 $16.45 3/31/20226,400 shares $99,712.00 +220.0%N/A0 $15.58 3/15/20222,000 shares $31,320.00 -75.3%N/A0 $15.66 2/28/20228,100 shares $135,108.00 -77.7%N/A0 $16.68 2/15/202236,300 shares $627,046.20 -17.7%N/A0.2 $17.27 1/31/202244,100 shares $712,215.00 -4.8%N/A0.2 $16.15 1/15/202246,300 shares $764,413.00 +282.6%N/A0.3 $16.51 12/31/202112,100 shares $196,867.00 -55.4%N/A0.1 $16.27 12/15/202127,100 shares $431,161.00 -13.1%N/A0.1 $15.91 11/30/202131,200 shares $485,316.00 -50.9%N/A0.2 $15.56 11/15/202163,500 shares $1.10 million -54.7%N/A0.9 $17.37 10/29/2021140,300 shares $2.37 million +17.3%N/A1.5 $16.88 10/15/2021119,600 shares $2.10 million +65.2%N/A1.1 $17.55 9/30/202172,400 shares $1.20 million +95.7%N/A0.8 $16.52 9/15/202137,000 shares $629,000.00 +380.5%N/A0.4 $17.00 8/31/20217,700 shares $129,206.00 +3,750.0%N/A0.1 $16.78 8/13/2021200 shares $3,246.00 -97.2%N/A0 $16.23 7/30/20217,200 shares $114,624.00 -36.8%N/A0.1 $15.92 7/15/202111,400 shares $198,474.00 -81.7%N/A0.1 $17.41 6/30/202162,400 shares $1.08 million +20.9%N/A0.6 $17.38 6/15/202151,600 shares $904,548.00 -28.3%N/A0.3 $17.53 5/28/202172,000 shares $1.17 million +410.6%N/A0.8 $16.22 5/14/202114,100 shares $215,166.00 +1,914.3%N/A0.1 $15.26Silent Raid on IRAs and 401(k)s Begins—Are You Next? (Ad)Look around—everything feels oddly steady. Gas prices aren't skyrocketing. Banks aren't collapsing. The markets? They're holding up—for now. But if history has taught us anything, it's this: when things feel too quiet, chaos is right around the corner.Avoid this chaos, click here to get your free guide. 4/30/2021700 shares $10,461.50 -82.1%N/A0 $14.95 4/15/20213,900 shares $58,812.00 -76.4%N/A0 $15.08 3/31/202116,500 shares $258,060.00 +66.7%N/A0.2 $15.64 3/15/20219,900 shares $164,835.00 -73.9%N/A0.1 $16.65 2/26/202137,900 shares $626,108.00 -41.4%N/A0.5 $16.52 2/12/202164,700 shares $1.10 million +462.6%N/A0.4 $16.99 1/29/202111,500 shares $188,370.00 -85.3%N/A0.1 $16.38 1/15/202140,400 shares $642,764.00 -34.0%N/A0.2 $15.91 12/31/202017,600 shares $271,040.00 -56.4%N/A0.1 $15.40 12/15/202040,400 shares $589,436.00 -34.0%N/A0.2 $14.59 11/30/202061,200 shares $954,108.00 +367.2%N/A0.5 $15.59 11/15/202013,100 shares $203,312.00 +718.8%N/A0.1 $15.52 10/30/20201,600 shares $22,256.00 -88.8%N/A0 $13.91 10/15/202014,300 shares $202,488.00 +44.4%N/A0.1 $14.16 9/30/20209,900 shares $147,609.00 +125.0%N/A0.1 $14.91 9/15/20204,400 shares $67,056.00 -91.3%N/A0 $15.24 8/31/202050,800 shares $796,036.00 +681.5%N/A0.4 $15.67 8/14/20206,500 shares $106,340.00 -59.4%N/A0.1 $16.36 7/31/202016,000 shares $251,168.00 +742.1%N/A0.1 $15.70 7/15/20201,900 shares $31,027.00 -96.6%N/A0 $16.33 6/30/202056,000 shares $932,960.00 +266.0%N/A0.6 $16.66 6/15/202015,300 shares $251,945.10 +393.6%N/A0.1 $16.47 5/29/20203,100 shares $55,304.00 -35.4%N/A0 $17.84 5/15/20204,800 shares $76,800.00 -66.0%N/A0.1 $16.00 4/30/202014,100 shares $230,535.00 +65.9%N/A0.1 $16.35 4/15/20208,500 shares $138,805.00 +7.6%N/A0.1 $16.33 3/31/20207,900 shares $129,165.00 -92.7%N/A0 $16.35 3/13/2020107,900 shares $1.67 million +233.0%N/A0.7 $15.52 ALPMY Short Interest - Frequently Asked Questions What is Astellas Pharma's current short interest? Short interest is the volume of Astellas Pharma shares that have been sold short but have not yet been closed out or covered. As of February 28th, traders have sold 57,000 shares of ALPMY short. 0.00% of Astellas Pharma's shares are currently sold short. Learn More on Astellas Pharma's current short interest. What is a good short interest percentage for Astellas Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Astellas Pharma's floating shares are currently sold short. Is Astellas Pharma's short interest increasing or decreasing? Astellas Pharma saw a increase in short interest in February. As of February 28th, there was short interest totaling 57,000 shares, an increase of 20.8% from the previous total of 47,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Astellas Pharma's short interest compare to its competitors? 0.00% of Astellas Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Astellas Pharma: Takeda Pharmaceutical Company Limited (0.14%), UCB SA (0.00%), UCB SA (0.21%), Alnylam Pharmaceuticals, Inc. (1.95%), Bayer Aktiengesellschaft (0.02%), Royalty Pharma plc (4.08%), Merck KGaA (0.00%), Teva Pharmaceutical Industries Limited (2.47%), Merck KGaA (0.43%), Genmab A/S (0.36%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks. What does it mean to sell short Astellas Pharma stock? Short selling ALPMY is an investing strategy that aims to generate trading profit from Astellas Pharma as its price is falling. ALPMY shares are trading down $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Astellas Pharma? A short squeeze for Astellas Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ALPMY, which in turn drives the price of the stock up even further. How often is Astellas Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALPMY, twice per month. The most recent reporting period available is February, 28 2025. More Short Interest Resources from MarketBeat Related Companies TAK Short Interest UCBJY Short Interest UCBJF Short Interest ALNY Short Interest BAYRY Short Interest RPRX Short Interest MKKGY Short Interest TEVA Short Interest MKGAF Short Interest GMAB Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ALPMY) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredWarning: What they're not telling you about these recent selloffsIn light of massive recent selloffs... our senior analyst Dan Ferris has issued a new warning for the American...Stansberry Research | SponsoredSilent Raid on IRAs and 401(k)s Begins—Are You Next?Look around—everything feels oddly steady. Gas prices aren't skyrocketing. Banks aren't collapsing. The mar...Genesis Gold Group | SponsoredWarren Buffet Just Made a $334 Billion BetDebt is out of control. Inflation is creeping back. And a major market downturn could be right around the corn...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astellas Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astellas Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALPMY Stock Alerts